A 42-day Parallel Group Safety Study of Revefenacin and Formoterol, Administered in Sequence and as a Combination, in Participants With COPD
Clinical trial NCT03573817 · COMPLETED
Trial details
- NCT number
- NCT03573817
- Sponsor
- Mylan Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-31
- Primary completion
- 2018-09-25
- Enrollment
- 122
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.